Medical and Surgical Treatment of Placenta Percreta to Optimize Bladder Preservation
Placenta percreta is associated with significant morbidity and mortality. Interventions are dictated by hemodynamic stability, desire to retain future fertility, and efforts to reduce surgical morbidity at time of delivery. Two cases of antenatally diagnosed placenta percreta with bladder invasion a...
Gespeichert in:
| Veröffentlicht in: | Obstetrics and gynecology (New York. 1953) 2008-08, Vol.112 (2), p.421-424 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 424 |
|---|---|
| container_issue | 2 |
| container_start_page | 421 |
| container_title | Obstetrics and gynecology (New York. 1953) |
| container_volume | 112 |
| creator | Lee, Paula S. Bakelaar, Ryan Fitpatrick, C Brennan Ellestad, Sarah C. Havrilesky, Laura J. Secord, Angeles Alvarez |
| description | Placenta percreta is associated with significant morbidity and mortality. Interventions are dictated by hemodynamic stability, desire to retain future fertility, and efforts to reduce surgical morbidity at time of delivery.
Two cases of antenatally diagnosed placenta percreta with bladder invasion are presented. Conservative management was used, including endovascular interventions, leaving the placenta in situ, methotrexate, and delayed hysterectomy. Postoperative outcomes were acceptable, with no significant hemorrhagic complications or need for extensive bladder reconstruction.
Antenatal diagnosis of placenta percreta with bladder invasion is essential in the multidisciplinary management of this potentially catastrophic condition. A comprehensive approach including delayed hysterectomy after medical management resulted in an excellent clinical outcome. |
| doi_str_mv | 10.1097/AOG.0b013e31817e7966 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69378980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69378980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4463-9f5314e1ee7d8e94c8326b31688e028191a653f32bef431ef8ba02f57ffadbf33</originalsourceid><addsrcrecordid>eNpdkU1v1DAQQC0EokvhHyCUC9xSxh7HH8dSQUEq2pVYJG6Wk4xpwEkWO6GCX49LV1RCPnjGejOjeWbsOYczDla_Pt9enkELHAm54Zq0VeoB23CjsRaIXx6yDYCwtTZSnrAnOX8DAK4sPmYn3ChltbQbtv9I_dD5WPmprz6t6evfZJ_ILyNNSzWHahd9V0Jf7Sh1iUqwzNX2sAzj8JuqN9H3PaVqlyhT-umXYZ6eskfBx0zPjvcp-_zu7f7ifX21vfxwcX5Vd1IqrG1okEviRLo3ZGVnUKgWuTKGQBhuuVcNBhQtBYmcgmk9iNDoEHzfBsRT9uqu7yHNP1bKixuH3FGMfqJ5za4sq401UEB5B3ZpzjlRcIc0jD79chzcrU1XbLr_bZayF8f-aztSf1901FeAl0fA5-ItJD91Q_7HCWgaNFbdz7-Z40Ipf4_rDSV3TT4u1678CyjRQC0ATDnA69snxD85MY2-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69378980</pqid></control><display><type>article</type><title>Medical and Surgical Treatment of Placenta Percreta to Optimize Bladder Preservation</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Lee, Paula S. ; Bakelaar, Ryan ; Fitpatrick, C Brennan ; Ellestad, Sarah C. ; Havrilesky, Laura J. ; Secord, Angeles Alvarez</creator><creatorcontrib>Lee, Paula S. ; Bakelaar, Ryan ; Fitpatrick, C Brennan ; Ellestad, Sarah C. ; Havrilesky, Laura J. ; Secord, Angeles Alvarez</creatorcontrib><description>Placenta percreta is associated with significant morbidity and mortality. Interventions are dictated by hemodynamic stability, desire to retain future fertility, and efforts to reduce surgical morbidity at time of delivery.
Two cases of antenatally diagnosed placenta percreta with bladder invasion are presented. Conservative management was used, including endovascular interventions, leaving the placenta in situ, methotrexate, and delayed hysterectomy. Postoperative outcomes were acceptable, with no significant hemorrhagic complications or need for extensive bladder reconstruction.
Antenatal diagnosis of placenta percreta with bladder invasion is essential in the multidisciplinary management of this potentially catastrophic condition. A comprehensive approach including delayed hysterectomy after medical management resulted in an excellent clinical outcome.</description><identifier>ISSN: 0029-7844</identifier><identifier>EISSN: 1873-233X</identifier><identifier>DOI: 10.1097/AOG.0b013e31817e7966</identifier><identifier>PMID: 18669749</identifier><identifier>CODEN: OBGNAS</identifier><language>eng</language><publisher>New York, NY: The American College of Obstetricians and Gynecologists</publisher><subject>Adult ; Biological and medical sciences ; Catheterization ; Delivery. Postpartum. Lactation ; Diseases of mother, fetus and pregnancy ; Disorders ; Embolization, Therapeutic ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Hysterectomy ; Medical sciences ; Methotrexate - therapeutic use ; Nucleic Acid Synthesis Inhibitors - therapeutic use ; Placenta Accreta - diagnosis ; Placenta Accreta - therapy ; Pregnancy ; Pregnancy. Fetus. Placenta ; Urinary Bladder Diseases - diagnosis ; Urinary Bladder Diseases - etiology ; Urinary Bladder Diseases - therapy</subject><ispartof>Obstetrics and gynecology (New York. 1953), 2008-08, Vol.112 (2), p.421-424</ispartof><rights>The American College of Obstetricians and Gynecologists</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4463-9f5314e1ee7d8e94c8326b31688e028191a653f32bef431ef8ba02f57ffadbf33</citedby><cites>FETCH-LOGICAL-c4463-9f5314e1ee7d8e94c8326b31688e028191a653f32bef431ef8ba02f57ffadbf33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20553896$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18669749$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Paula S.</creatorcontrib><creatorcontrib>Bakelaar, Ryan</creatorcontrib><creatorcontrib>Fitpatrick, C Brennan</creatorcontrib><creatorcontrib>Ellestad, Sarah C.</creatorcontrib><creatorcontrib>Havrilesky, Laura J.</creatorcontrib><creatorcontrib>Secord, Angeles Alvarez</creatorcontrib><title>Medical and Surgical Treatment of Placenta Percreta to Optimize Bladder Preservation</title><title>Obstetrics and gynecology (New York. 1953)</title><addtitle>Obstet Gynecol</addtitle><description>Placenta percreta is associated with significant morbidity and mortality. Interventions are dictated by hemodynamic stability, desire to retain future fertility, and efforts to reduce surgical morbidity at time of delivery.
Two cases of antenatally diagnosed placenta percreta with bladder invasion are presented. Conservative management was used, including endovascular interventions, leaving the placenta in situ, methotrexate, and delayed hysterectomy. Postoperative outcomes were acceptable, with no significant hemorrhagic complications or need for extensive bladder reconstruction.
Antenatal diagnosis of placenta percreta with bladder invasion is essential in the multidisciplinary management of this potentially catastrophic condition. A comprehensive approach including delayed hysterectomy after medical management resulted in an excellent clinical outcome.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Catheterization</subject><subject>Delivery. Postpartum. Lactation</subject><subject>Diseases of mother, fetus and pregnancy</subject><subject>Disorders</subject><subject>Embolization, Therapeutic</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hysterectomy</subject><subject>Medical sciences</subject><subject>Methotrexate - therapeutic use</subject><subject>Nucleic Acid Synthesis Inhibitors - therapeutic use</subject><subject>Placenta Accreta - diagnosis</subject><subject>Placenta Accreta - therapy</subject><subject>Pregnancy</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Urinary Bladder Diseases - diagnosis</subject><subject>Urinary Bladder Diseases - etiology</subject><subject>Urinary Bladder Diseases - therapy</subject><issn>0029-7844</issn><issn>1873-233X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQQC0EokvhHyCUC9xSxh7HH8dSQUEq2pVYJG6Wk4xpwEkWO6GCX49LV1RCPnjGejOjeWbsOYczDla_Pt9enkELHAm54Zq0VeoB23CjsRaIXx6yDYCwtTZSnrAnOX8DAK4sPmYn3ChltbQbtv9I_dD5WPmprz6t6evfZJ_ILyNNSzWHahd9V0Jf7Sh1iUqwzNX2sAzj8JuqN9H3PaVqlyhT-umXYZ6eskfBx0zPjvcp-_zu7f7ifX21vfxwcX5Vd1IqrG1okEviRLo3ZGVnUKgWuTKGQBhuuVcNBhQtBYmcgmk9iNDoEHzfBsRT9uqu7yHNP1bKixuH3FGMfqJ5za4sq401UEB5B3ZpzjlRcIc0jD79chzcrU1XbLr_bZayF8f-aztSf1901FeAl0fA5-ItJD91Q_7HCWgaNFbdz7-Z40Ipf4_rDSV3TT4u1678CyjRQC0ATDnA69snxD85MY2-</recordid><startdate>20080801</startdate><enddate>20080801</enddate><creator>Lee, Paula S.</creator><creator>Bakelaar, Ryan</creator><creator>Fitpatrick, C Brennan</creator><creator>Ellestad, Sarah C.</creator><creator>Havrilesky, Laura J.</creator><creator>Secord, Angeles Alvarez</creator><general>The American College of Obstetricians and Gynecologists</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080801</creationdate><title>Medical and Surgical Treatment of Placenta Percreta to Optimize Bladder Preservation</title><author>Lee, Paula S. ; Bakelaar, Ryan ; Fitpatrick, C Brennan ; Ellestad, Sarah C. ; Havrilesky, Laura J. ; Secord, Angeles Alvarez</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4463-9f5314e1ee7d8e94c8326b31688e028191a653f32bef431ef8ba02f57ffadbf33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Catheterization</topic><topic>Delivery. Postpartum. Lactation</topic><topic>Diseases of mother, fetus and pregnancy</topic><topic>Disorders</topic><topic>Embolization, Therapeutic</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hysterectomy</topic><topic>Medical sciences</topic><topic>Methotrexate - therapeutic use</topic><topic>Nucleic Acid Synthesis Inhibitors - therapeutic use</topic><topic>Placenta Accreta - diagnosis</topic><topic>Placenta Accreta - therapy</topic><topic>Pregnancy</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Urinary Bladder Diseases - diagnosis</topic><topic>Urinary Bladder Diseases - etiology</topic><topic>Urinary Bladder Diseases - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Paula S.</creatorcontrib><creatorcontrib>Bakelaar, Ryan</creatorcontrib><creatorcontrib>Fitpatrick, C Brennan</creatorcontrib><creatorcontrib>Ellestad, Sarah C.</creatorcontrib><creatorcontrib>Havrilesky, Laura J.</creatorcontrib><creatorcontrib>Secord, Angeles Alvarez</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Paula S.</au><au>Bakelaar, Ryan</au><au>Fitpatrick, C Brennan</au><au>Ellestad, Sarah C.</au><au>Havrilesky, Laura J.</au><au>Secord, Angeles Alvarez</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical and Surgical Treatment of Placenta Percreta to Optimize Bladder Preservation</atitle><jtitle>Obstetrics and gynecology (New York. 1953)</jtitle><addtitle>Obstet Gynecol</addtitle><date>2008-08-01</date><risdate>2008</risdate><volume>112</volume><issue>2</issue><spage>421</spage><epage>424</epage><pages>421-424</pages><issn>0029-7844</issn><eissn>1873-233X</eissn><coden>OBGNAS</coden><abstract>Placenta percreta is associated with significant morbidity and mortality. Interventions are dictated by hemodynamic stability, desire to retain future fertility, and efforts to reduce surgical morbidity at time of delivery.
Two cases of antenatally diagnosed placenta percreta with bladder invasion are presented. Conservative management was used, including endovascular interventions, leaving the placenta in situ, methotrexate, and delayed hysterectomy. Postoperative outcomes were acceptable, with no significant hemorrhagic complications or need for extensive bladder reconstruction.
Antenatal diagnosis of placenta percreta with bladder invasion is essential in the multidisciplinary management of this potentially catastrophic condition. A comprehensive approach including delayed hysterectomy after medical management resulted in an excellent clinical outcome.</abstract><cop>New York, NY</cop><pub>The American College of Obstetricians and Gynecologists</pub><pmid>18669749</pmid><doi>10.1097/AOG.0b013e31817e7966</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0029-7844 |
| ispartof | Obstetrics and gynecology (New York. 1953), 2008-08, Vol.112 (2), p.421-424 |
| issn | 0029-7844 1873-233X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69378980 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adult Biological and medical sciences Catheterization Delivery. Postpartum. Lactation Diseases of mother, fetus and pregnancy Disorders Embolization, Therapeutic Female Gynecology. Andrology. Obstetrics Humans Hysterectomy Medical sciences Methotrexate - therapeutic use Nucleic Acid Synthesis Inhibitors - therapeutic use Placenta Accreta - diagnosis Placenta Accreta - therapy Pregnancy Pregnancy. Fetus. Placenta Urinary Bladder Diseases - diagnosis Urinary Bladder Diseases - etiology Urinary Bladder Diseases - therapy |
| title | Medical and Surgical Treatment of Placenta Percreta to Optimize Bladder Preservation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T01%3A42%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20and%20Surgical%20Treatment%20of%20Placenta%20Percreta%20to%20Optimize%20Bladder%20Preservation&rft.jtitle=Obstetrics%20and%20gynecology%20(New%20York.%201953)&rft.au=Lee,%20Paula%20S.&rft.date=2008-08-01&rft.volume=112&rft.issue=2&rft.spage=421&rft.epage=424&rft.pages=421-424&rft.issn=0029-7844&rft.eissn=1873-233X&rft.coden=OBGNAS&rft_id=info:doi/10.1097/AOG.0b013e31817e7966&rft_dat=%3Cproquest_cross%3E69378980%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69378980&rft_id=info:pmid/18669749&rfr_iscdi=true |